Fraunhofer Institute for Material and Beam Technology IWSCharacterization of Therapeutic Modulation of Organ Fibrosis in Biochip Format for Drug Development
Project Description
FIBROPATHS® focuses on the effective, rapid, and safe development of anti-fibrotic drugs.
Fibrosis is the pathological proliferation of connective tissue in diseased organs such as the lungs, heart, and liver, and there is currently no effective treatment for its underlying causes. It is directly or indirectly responsible for around 45 % of all deaths. More than 100 million patients worldwide urgently need new perspectives for the treatment of organ fibrosis, e.g., after a heart attack, in connection with chronic lung diseases, or after liver damage caused by toxic or metabolic influences.
